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ABSTRACT
Objectives: The aim of this study was to investigate whether severe preeclampsia (SPE) affects intraocular pressure (IOP) 
and ocular perfusion pressure (OPP).
Material and methods: This prospective and comparative study included 64 pregnant females, allocated into 2 groups 
as Group 1 (31 pregnant women with SPE) and Group 2 (33 normotensive pregnant women). IOP, systolic and diastolic 
blood pressure, OPP of all the subjects were measured after 20 weeks of gestation and prior to labor and medical therapy.
Results: The mean IOP values in Group 1 were not significantly different from those of Group 2 (p = 0.528). The mean OPP 
values in Group 1 were significantly higher than those of Group 2 (p < 0.001). There was no significant correlation between 
IOP and OPP levels. No significant differences were determined between the groups in respect of age, gestational age body 
mass index (BMI) (p < 0.269, p < 0.219 and p < 0.556 respectively). The mean systolic and diastolic blood pressure values 
were statistically significantly higher in Group 1 than in Group 2 (p < 0.001 and p < 0.001).
Conclusions: Although high IOP was expected in SPE patients, it was found to be constant. This could have been due to 
an increase in aqueous humor outflow because of changes occurring in angiogenic and anti-angiogenic factors in SPE.
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INTRODUCTION
Preeclampsia (PE) is defined as a pregnancy-specific 
hypertensive disease, developing in the 2nd or 3rd trimester 
as a complication of 2%–7% of pregnancies [1]. It refers to 
the new onset of hypertension and proteinuria or end-or-
gan dysfunction after 20 weeks of gestation in previously 
normotensive women [2] and is a leading cause of maternal 
and perinatal morbidity and mortality [3]. SPE is one of the 
worst sequlae of hypertensive disorders in pregnancy. SPE 
with estimated incidence of 0.6%–1.2% [4], is an uncommon 
hypertensive disorder in pregnancy that is characterized by 
excessive maternal systemic inflammation and endothelial 
dysfunction [5]. This results in temporary ischemic injury of 
many body organ systems.
The visual system may be affected to different degrees in 
PE. Ocular symptoms in patients with PE are caused by vari-
ous underlying pathological changes in the retina, cerebral 
cortex, and optic nerve [6]. Recent studies have shown that 
women with a history of PE remain at higher risk for ocular 
complications than healthy pregnant women during the 
intrapartum and postpartum period [7, 8]. Although most of 
the ocular changes in pregnancy are physiological, in cases 
with PE these may be pathological.
Although ocular changes in women with PE have been 
investigated in many studies, there remains a need for fur-
ther studies to determine ocular disorders that emerge in 
PE [9]. In these previous studies, SPE and mild preeclamptic 
cases have been evaluated in the same pool and to the best 
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of our knowledge there has been no study that has evalu-
ated IOP and OPP in isolated SPE patients. There have been 
found to be conflicting results in the data obtained from 
studies conducted on PE patients for other purposes. The 
aim of this study was to investigate the possible effect of SPE 
on IOP and OPP during pregnancy and thereby contribute 
to literature.
MATERIAL AND METHODS
This multi-center prospective case-control study was 
conducted by the Department of Gynecology and Obstetrics 
Departments and Ophthalmology Departments of Kafkas 
University Medical Faculty Hospital (KUMFH) and Kahra-
manmaras Sutcu Imam University Medical Faculty Hospital 
(KSUMFH). The study protocol adhered to the tenets of the 
Declaration of Helsinki and approval was granted by the 
KUMFH Institutional Eethics Committee (date: 25 October 
2017). The study included all consecutive patients after the 
20th week of gestation who were treated in the KUMFH 
and KSUMFH for SPE between November 2017 and April 
2018. All subjects provided informed consent for partici-
patione in the study. 
Patient selection
The study included 31 pregnant women complicated 
by SPE (Group 1) and 33 healthy pregnant women (Group 
2) matched for age, gestational age and BMI. BMI was cal-
culated from height and weight measurements. The 31 SPE 
patients and 33 healthy pregnant women, aged 18–40 years, 
were recruited from the antenatal clinics of the above-men-
tioned hospitals. None of the participants were in active 
labor or had received any volume expansion or magnesium 
sulphate therapy before the ophthalmic examination.
SPE diagnosis was made according to the following 
criteria [2]: The Task Force on Hypertension in Pregnancy 
defined SPE as severe hypertension [after 20 weeks of ges-
tation with a previously normal blood pressure, systolic 
blood pressure of ≥ 160 mm Hg or diastolic blood pressure 
of ≥ 110 mm Hg on two occasions at least 4 hours apart while 
the patient is on bed rest (unless antihypertensive therapy 
is initiated before this time)] and proteinuria [≥ 300 mg 
per 24-hour urine collection (or this amount extrapolated 
from a timed collection) or protein/creatinine ratio ≥ 0.3 or 
dipstick reading of 1+] in the absence of proteinuria with 
new-onset hypertension [after 20 weeks of gestation with 
a previously normal blood pressure, systolic blood pressure 
of ≥ 140 mm Hg or diastolic blood pressure of ≥ 90 mm Hg 
on two occasions at least 4 hours apart] with the new onset 
of any of the following features: thrombocytopenia [platelet 
count < 100,000/µL], progressive renal insufficiency [serum 
creatinine concentration > 1.1 mg/dL or a doubling of the 
serum creatinine concentration in the absence of other renal 
disease], pulmonary edema, new-onset of cerebral or visual 
disturbances and impaired liver function as indicated by 
abnormally elevated blood concentrations of liver enzymes 
(to twice normal concentration), severe persistent right up-
per quadrant or epigastric pain unresponsive to medication 
and not accounted for by alternative diagnoses, or both.
Patients were excluded if they had twin pregnancy, 
gestational hypertension, chronic hypertension, mild 
preeclampsia, renal disease, diabetes mellitus, gestational 
diabetes mellitus, overt cardiovascular disease or if they 
smoked. Women with a history of glaucoma, glaucomatous 
optic disc changes, papillary hemorrhage, glaucomatous 
visual field defects, IOP readings > 22 mm Hg, any findings 
associated with elevated IOP (shallow anterior chamber, 
pseudoexfoliation syndrome), high spherical and ciliary 
refractive errors (myopia, hypermetropia, astigmatism), or 
a history of previous intraocular surgery or laser therapy 
were also excluded.
IOP and OPP measurements
To avoid the effects of seasonal variations on IOP, this 
study was conducted in the winter season [10]. As previous 
studies have demonstrated a circadian rhythm of aqueous 
humor flow the IOP and OPP measurements in the current 
study were taken in the morning in both the patients and 
control groups, thereby avoiding potential bias. After rest-
ing for at least 15 minutes, brachial blood pressure was 
recorded using an automated oscillometric machine from 
the upper arm, with the patient in a seated position. IOP is 
dynamic and determined by several variables. The relation-
ship between IOP and these variables can be modeled by 
the modified Goldmann equation: IOP = EVP + (Q – U)/c; 
where EVP is the episcleral venous pressure, Q is the aque-
ous humor flow rate, c is the conventional outflow facility, 
and U is the pressure-insensitive uveoscleral outflow rate 
[11]. IOP was measured at least 3 times using an I-Care re-
bound tonometer (ICare TA01; Tiolat, Helsinki, Finland). The 
mean value was used for analysis [12]. OPP was calculated 
based on mean arterial pressure (MAP) and IOP accord-
ing to the following formula: mean OPP = 2/3 (MAP-IOP). 
MAP was obtained from systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) using the following formula: 
MAP = DBP + 1/3 (SBP-DBP).
The IOP and OPP of all subjects both in SPE and control 
groups were measured after the 20th week of gestation. 
The measurements of all patients with SPE were evaluated 
prior to active labor or volume expansion therapy or mag-
nesium sulphate therapy. The IOP measurements of both 
eyes of each participant were taken with the same I-Care 
rebound tonometer. The measurements of the right eyes 
were included in this study. Full ophthalmologic evaluations, 
including best-correct visual acuity, slit-lamp and dilated 
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fundus evaluation, were performed when the general state 
was stable.
Statistical analysis
The data of the right eye of each patient were analysed. 
All statistical analyses were performed using Statistical Pack-
age for the Social Sciences Software, version 24.0 (SPSS 
Inc., Chicago, IL. USA) program. The conformity of the data 
to normal distribution was confirmed using the Kolmog-
orov-Smirnov test. The Mann-Whitney U test was used to 
compare variables between groups. Pearson’s correlation 
was used to examine the relationships between IOP and 
OPP. The results were given as mean ± standard deviation 
(SD) and p < 0.05 was considered statistically significant. 
RESULTS
The clinical and demographic characteristics of the 
31 SPE women (Group 1) and 33 normotensive pregnant 
women (Group 2) are summarized in Table 1. There were no 
significant differences between the groups in respect of age 
(30.23 ± 2.88 years vs 31.30 ± 4.68 years; p = 0.269), gestational 
age (33.45 ± 2.81 weeks vs 32.27 ± 4.61 weeks; p =0 .219) and 
BMI (31.52 ± 2.40 v.s 31.12 ± 2.95 p = 0.556). Group 1 had a sig-
nificantly higher systolic blood pressure (159.84 ± 6.38 mm 
Hg vs 114.24 ± 5.01 mm Hg; p < 0.001), diastolic blood pres-
sure (98.55 ± 6.73 mm Hg vs 75.15 ± 5.07 mm Hg; p < 0.001) 
and MAP (118.50 ± 6.45 mm Hg vs 88.15 ± 3.92 mm Hg; 
p < 0.001) than Group 2. The mean IOP values in Group 
1 were not significantly different from those of Group 
2 (14.32 ± 3.87 vs 13.79 ± 2.80; p = 0.528). The mean OPP 
values in Group 1 were significantly higher than those of 
Group 2 (69.42 ± 5.38 vs 48.34 ± 6.42; p < 0.001). There was 
no significant correlation between IOP and OPP levels. No 
significant correlation was determined between the meas-
ured parameters, and the IOP, and OPP values. Although 
reported in literature, no cases of vitreous hemorrhage, 
serous retinal detachment, Purstcher like retinopathy or 
cortical blindness were encountered in this study.
DISCUSSION
PE is a multifactorial disease, characterized by systemic 
endothelial dysfunction [5]. The effects of PE are differ-
ent from the effects of hypertension alone, which is the 
most basic feature [13]. During PE, both endothelial de-
rived growth factors and pro-inflammatory molecules may 
lead to vasculopathic ophthalmic conditions. As changes 
in angiogenic and anti-angiogenic factors in SPE [14] could 
cause an increase in aqueous humor outflow and because 
of the balance between these two conditions, it is thought 
that IOP could remain constant. If the changes in these 
factors are responsible for the IOP remaining constant, the 
measurement of IOP could be a marker for preeclampsia 
that is simple to apply. Unlike previous studies where mild 
and SPE cases have been studied together, only women 
with SPE were evaluated in the current study. Both the SPE 
patients and the control group were in the third trimester 
of pregnancy. In the comparison of the SPE patients with 
the normotensive women while OPP values were found to 
be significantly higher in the SPE patients no significant 
difference was seen in the IOP values. 
Due to the major physiological changes in pregnancy, 
changes are seen in IOP, corneal thickness, and some visual 
functions such as accommodation and visual field [15]. In 
a recent meta-analysis, IOP values of healthy pregnant 
women in the third trimester have been shown to be lower 
than those of non-pregnant women [16]. The physiological 
Table 1. The demographic and clinical characteristics of pregnant women with severe preeclampsia and normotensive pregnant 
women
Variables
Pregnant women with severe 
preeclampsia
(Group 1)
n: 31
Normotensive pregnant 
women
(Group 2)
n: 33
pa
Age [years] 30.23 ± 2.88 31.30 ± 4.68 0.269
BMI [kg/m2] 31.52 ± 2.40 31.12 ± 2.95 0.556
Gestational age [week] 33.45 ± 2.81 32.27 ± 4.61 0.219
Systolic Blood pressure [mmHg] 159.84 ± 6.38 114.24 ± 5.01 < 0.001*
Diastolic Blood pressure [mm Hg] 98.55 ± 6.73 75.15 ± 5.07 < 0.001*
MAP 118.50 ± 6.45 88.15 ± 3.92 < 0.001*
IOP 14.32 ± 3.87 13.79 ± 2.80 0.528
OPP 69.42 ± 5.38 48.34 ± 6.42 < 0.001*
Results are given in mean ± SD.a Mann-Whitney U test were used. A P value of < 0.05 was considered as significant (*). BMI — body mass index; IOP — intraocular 
pressure; MAP — mean arterial pressure; OPP — ocular perfusion pressure
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mechanisms responsible for the decrease of IOP during 
pregnancy are not clearly known [17]. Due to a rise in the 
levels of progesterone during pregnancy either directly or 
indirectly cause an increase in fluid outflow from the eye 
without altering the rate of fluid entry. 2–3 mm Hg decrease 
in episcleral venous pressure during pregnancy may affect 
fluid outflow from the eye [18, 19]. 
Pregnancy is known to have a beneficial impact on many 
ocular defects including glaucoma [10, 20]. Hence, physi-
ological changes in pregnancy may normalize IOP levels in 
women with ocular hypertension [21]. In agreement with 
this, decreased IOP has been reported in both normotensive 
[20] and hypertensive pregnant women [10]. It has also 
been reported that pregnancy leads to a decline in IOP of 
up to 20% in healthy normotensive women [21]. Likewise, 
in pregnant subjects with ocular hypertension, pregnancy 
leads to a decline in IOP of up to 25% [21].
Although there is no specific research in literature related 
to the effect of SPE on IOP and OPP, conflicting results have 
been reported. Qureshi et al reported that the mean IOP val-
ues of hypertensive pregnant women in the third trimester 
were statistically significantly higher than those of patients 
who were not hypertensive. However, that study excluded 
patients with PE [10]. In a study by Giannia et al, the IOP val-
ues of preeclamptic women were reported to be increased 
in the peripartum period compared to normotensive preg-
nant women. Patients with SPE were not evaluated in that 
study, and unlike the our study, patients in the postpartum 
period were included [22]. Philips et al. found no difference 
in third trimester IOP values between hypertensive and 
non-hypertensive pregnant women. However, in that study 
there were no data whether pregnant patients had PE [23]. 
The IOP and OPP findings reported by Sayın et al of pregnant 
women with PE were similar to our results [24].
High systolic blood pressure causes high IOP [25–27]. In 
contrast, IOP levels did not rise and remained constant in 
pregnant women with SPE. Factors affecting the formation 
of IOP may be responsible for unchanged IOP levels. Aque-
ous humor flow rate is the most important contributor of 
aqueous humor formation [11]. It has been reported that 
aqueous humor flow could be affected with the effect of 
episcleral venous pressure associated with high pressure 
[28, 29]. Normal IOP levels in SPE cases are suggesting the 
lack of resistance to aqueous humor outflow throughout 
the episcleral pathways.
Hormonal milieu, endothelial damage, hypoperfusion 
ischemia, hyperperperfusion edema and abnormal au-
toregulation may affect ocular changes in PE [20]. The most 
frequently seen ophthalmological abnormalities in preec-
lamptic women are retinal artery spasm [30] and orbital 
vascular hyperperfusion [31]. The prevalence of vascular 
spasm and resistance in preeclampsia patients is expected 
to cause an increase in upper extremity venous pressure. 
Hence, both episcleral venous pressure and IOP are expect-
ed to rise. In addition, an enhancement in the production of 
aqueous humor in preeclamptic patients is thought to be 
a result of both increased retinal blood flow and siliceous 
cell blood flow. However, as the IOP was determined to be 
constant in the preeclampsia patients in the current study, 
a significant enhancement in the aqueous humor flow or 
reduction in the production of aqueous humor may keep 
the IOP values constant. 
CONCLUSIONS
In conclusion, constant IOP levels in SPE patients may 
be due to increased aqueous humor outflow. In the light of 
these findings, there is a need for further studies to reach 
firmer conclusions about the impact of SPE on aqueous 
humor flow.
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